Retour sur lavenir.net
   D'IETEREN GROUP 172.900 € (+1,23 %)     LOTUS BAKERIES 11 220.000 € (-0,88 %)     KBC ANCORA 84.300 € (+0,96 %)     WERELDHAVE BELGIUM 52.800 € (0,00 %)     ACKERMANS V.HAAREN 268.000 € (-0,52 %)     EVS 27.250 € (+0,93 %)     FAGRON 23.750 € (-0,84 %)     AZELIS GROUP 10.240 € (+3,43 %)     AB INBEV 69.660 € (+0,66 %)     UMICORE 20.060 € (+0,20 %)     SYENSQO 66.000 € (+0,61 %)     BEKAERT 39.900 € (+0,63 %)     KBC 120.200 € (+0,63 %)     ORANGE BELGIUM 21.500 € (0,00 %)     KINEPOLIS GROUP 36.400 € (+1,53 %)     TUBIZE-FIN 208.600 € (-4,84 %)     BPOST 1.590 € (-1,12 %)     VASTNED 29.400 € (+0,51 %)     NYXOAH 1.516 € (+0,93 %)     SIPEF 90.500 € (+0,56 %)     ARGENX SE 763.800 € (-4,14 %)     DECEUNINCK 2.235 € (-0,22 %)     PROXIMUS 5.925 € (+1,28 %)     ACCENTIS 0.027 € (0,00 %)     CMB.TECH 13.420 € (+3,23 %)     HOME INVEST BE. 18.940 € (-0,42 %)     XIOR 27.400 € (0,00 %)     COLRUYT 36.880 € (+0,77 %)     MONTEA 67.100 € (+0,45 %)     CARE PROPERTY INV. 12.600 € (-0,32 %)     SOFINA 226.400 € (+0,18 %)     QUESTFOR GR-PRICAF 2.920 € (-1,03 %)     VGP 81.400 € (-0,37 %)     QRF 10.150 € (0,00 %)     VIOHALCO 17.800 € (+0,79 %)     IBA 16.640 € (-0,48 %)     BREDERODE 103.400 € (-0,96 %)     ONWARD MEDICAL 2.510 € (+0,40 %)     SHURGARD 26.300 € (+0,19 %)     TITAN S.A. 50.550 € (+0,90 %)     ATENOR 1.625 € (+1,56 %)     ASCENCIO 51.400 € (-0,58 %)     ENERGYVISION 14.900 € (+0,54 %)     UCB 237.100 € (-5,16 %)     ONTEX GROUP 2.210 € (+0,23 %)     SOLVAY 26.080 € (-0,08 %)     ELIA GROUP 136.700 € (+0,96 %)     IMMOBEL 22.000 € (-0,90 %)     RECTICEL 11.420 € (+1,96 %)     JENSEN-GROUP 81.600 € (0,00 %)     ECONOCOM GROUP 1.420 € (+0,71 %)     TINC 11.280 € (-0,18 %)     GIMV 44.800 € (+0,11 %)     GBL 77.750 € (-0,45 %)     RETAIL ESTATES 68.200 € (-0,29 %)     BARCO 8.365 € (-0,65 %)     DEME GROUP 168.600 € (-0,24 %)     WDP 21.820 € (0,00 %)     VAN DE VELDE 29.900 € (-0,33 %)     AEDIFICA 69.200 € (-0,07 %)  
   AALBERTS NV 39.300 € (-0,41 %)     BNP PARIBAS ACT.A 100.700 € (+0,88 %)     ASML HOLDING 1 569.000 € (-2,11 %)     LVMH 489.900 € (-0,62 %)     INVENTIVA 3.730 € (0,00 %)     SANOFI 76.230 € (-0,33 %)     SCOR SE 31.880 € (+1,01 %)     PHILIPS KON 24.060 € (+0,59 %)     SCHNEIDER ELECTRIC 269.650 € (-0,13 %)     AVANTIUM 7.090 € (+0,28 %)     ARCADIS 34.520 € (+0,88 %)     CARREFOUR 16.490 € (+0,95 %)     AIRBUS 197.260 € (+0,38 %)     PERNOD RICARD 64.200 € (+0,94 %)     VINCI 119.000 € (-0,29 %)     POUJOULAT 5.400 € (+0,37 %)     CELLECTIS 2.590 € (-4,15 %)     STMICROELECTRONICS 62.000 € (-1,08 %)     FORVIA 9.082 € (+0,89 %)     SMCP 5.170 € (-0,19 %)     2CRSI 30.700 € (-3,46 %)     S.E.B. 46.640 € (-0,04 %)     NANOBIOTIX 35.560 € (+4,28 %)     ASM INTERNATIONAL 910.400 € (-1,77 %)     PLANISWARE 20.550 € (+0,24 %)     MAUREL ET PROM 7.785 € (-1,64 %)     NEXITY 7.575 € (0,00 %)     THALES 223.300 € (-1,54 %)     SOITEC 98.000 € (-5,86 %)     CREDIT AGRICOLE 17.490 € (+0,37 %)     DBV TECHNOLOGIES 2.852 € (+0,07 %)     SARTORIUS STED BIO 183.300 € (+2,06 %)     MEXEDIA 3.630 € (-5,84 %)     VOLTALIA 6.900 € (-2,13 %)     CAPGEMINI 88.960 € (-0,04 %)     MEDINCELL 27.100 € (-2,66 %)     SES 7.705 € (-1,03 %)     INPOST 15.470 € (+0,32 %)     MAGNUM 16.308 € (+2,40 %)     COMPAGNIE ODET 1 456.000 € (-0,41 %)     ING GROEP N.V. 28.415 € (-0,05 %)     AIR LIQUIDE 174.300 € (+0,77 %)     DANONE 72.420 € (0,00 %)     ORANGE 15.870 € (+0,03 %)     GREEN EARTH GROUP 1.180 € (+3,06 %)     LAKEFRONT BIOTHER. 26.320 € (-1,20 %)     BENETEAU 6.070 € (-0,49 %)     STREAMWIDE 71.000 € (-6,58 %)     GETLINK SE 18.480 € (-0,65 %)     NEXANS 134.000 € (+0,90 %)     HEIJMANS KON 100.100 € (-4,03 %)     KERLINK 1.165 € (-3,72 %)     NRJ GROUP 6.840 € (-0,58 %)     CRCAM NORM.SEINE 162.500 € (-0,61 %)     FUGRO 9.675 € (+0,52 %)     TOMTOM 4.600 € (-0,22 %)     CA TOULOUSE 31 CCI 128.000 € (-4,32 %)     CORBION 20.520 € (-0,39 %)     NACON 0.206 € (-2,83 %)     HIPAY GROUP 5.460 € (-2,15 %)  
News Réglementées
19/04/2023 13:34

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

19-Apr-2023 / 12:34 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

17 April 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,583,259

9.43%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,583,259

9.43%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

5,539

111.99 USD

US$0.0001 ordinary shares

Sale

462

111.99 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 none

<

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière